| Metric | Q1'26 | Q2'26 | Change |
|---|---|---|---|
| Revenue | $18.5B (Q1, +4.3% YoY) | $19.6B (Q2, +5.5% YoY) | +120 bps acceleration |
| Adjusted EBITDA | $3.62B (Q1, +1.9% YoY) | $3.95B (Q2, +5.0% YoY) | +310 bps acceleration |
| Diluted EPS | $6.65 (Q1, +11% YoY) | $7.25 (Q2, +11% YoY) | Flat growth rate |
| Same-facility admissions | +0.9% (Q1) | +2.5% (Q2) | +160 bps acceleration |
| Same-facility equivalent admissions | +1.3% (Q1) | +2.7% (Q2) | +140 bps acceleration |
| Inpatient surgeries | -0.3% (Q1) | -2.3% (Q2) | 200 bps deterioration |
| Outpatient surgeries | -1.7% (Q1) | -3.4% (Q2) | 170 bps deterioration |
| Emergency room visits | +0.3% (Q1) | +3.6% (Q2) | +330 bps acceleration |
| Exchange equivalent admissions | -15% (Q1) | -15% (Q2) | Stable decline rate |
| Uninsured equivalent admissions | +16% (Q1) | +15% (Q2) | Slight deceleration |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.